Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Isenberg

Showing results (131-140 of 280) with videos related to

Pageof 28
Sort By:
European Journal of Internal Medicine|July 13, 2004
Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopeniaJosé Delgado Alves, Murat Inanc, Reyhan Diz-Kucukkaya, et al.
Seminars in Arthritis and Rheumatism|December 11, 2024
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" working group report on strengths and limitationsGustavo G M Balbi, Pedro Gaspar, Hannah Cohen, et al.
Rheumatology (Oxford, England)|March 30, 2026
Assessment of the use of biologic drugs in the treatment of primary antiphospholipid syndromeMaryia Nikitsina, Marta Ramírez Martín, Carlota Navarro-Joven, et al.
The Journal of Clinical Investigation|April 16, 2004
Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosusElizabeth C Jury, Panagiotis S Kabouridis, Fabian Flores-Borja, et al.
Lancet (London, England)|December 4, 2003
Diagnostic criteria for polymyositis and dermatomyositisFrederick W Miller, Lisa G Rider, Paul H Plotz, et al.
Rheumatology (Oxford, England)|October 8, 2015
Musculoskeletal complications of haematological diseaseSandra A Morais, Hannah E du Preez, Mohammed Rashid Akhtar, et al.
Current Rheumatology Reports|July 22, 2017
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: CommentHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2015
Internalization of rituximab and the efficiency of B Cell depletion in rheumatoid arthritis and systemic lupus erythematosusVenkat Reddy, Geraldine Cambridge, David A Isenberg, et al.
Arthritis and Rheumatism|December 2, 2006
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control studyRupa Bessant, Rachel Duncan, Gareth Ambler, et al.
Nature Reviews. Rheumatology|November 19, 2025
Insights into the pathogenesis of childhood-onset SLE in the past decadeGeorge A Robinson, Andrea Knight, Lori B Tucker, et al.
Pageof 28

Showing results (131-140 of 280) with videos related to

Sort By:
Pageof 28
European Journal of Internal Medicine|July 13, 2004
Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopeniaJosé Delgado Alves, Murat Inanc, Reyhan Diz-Kucukkaya, et al.
Seminars in Arthritis and Rheumatism|December 11, 2024
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" working group report on strengths and limitationsGustavo G M Balbi, Pedro Gaspar, Hannah Cohen, et al.
Rheumatology (Oxford, England)|March 30, 2026
Assessment of the use of biologic drugs in the treatment of primary antiphospholipid syndromeMaryia Nikitsina, Marta Ramírez Martín, Carlota Navarro-Joven, et al.
The Journal of Clinical Investigation|April 16, 2004
Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosusElizabeth C Jury, Panagiotis S Kabouridis, Fabian Flores-Borja, et al.
Lancet (London, England)|December 4, 2003
Diagnostic criteria for polymyositis and dermatomyositisFrederick W Miller, Lisa G Rider, Paul H Plotz, et al.
Rheumatology (Oxford, England)|October 8, 2015
Musculoskeletal complications of haematological diseaseSandra A Morais, Hannah E du Preez, Mohammed Rashid Akhtar, et al.
Current Rheumatology Reports|July 22, 2017
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: CommentHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2015
Internalization of rituximab and the efficiency of B Cell depletion in rheumatoid arthritis and systemic lupus erythematosusVenkat Reddy, Geraldine Cambridge, David A Isenberg, et al.
Arthritis and Rheumatism|December 2, 2006
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control studyRupa Bessant, Rachel Duncan, Gareth Ambler, et al.
Nature Reviews. Rheumatology|November 19, 2025
Insights into the pathogenesis of childhood-onset SLE in the past decadeGeorge A Robinson, Andrea Knight, Lori B Tucker, et al.
Pageof 28